Skin clues could unmask rare nerve disease in kids

NCT ID NCT03893643

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study looks at children under 15 with neurofibromatosis type 2 (NF2), a rare genetic condition that causes nerve tumors. Researchers want to see if skin and mouth lesions can help diagnose NF2 earlier than current methods, which rely on hearing, nerve, and eye symptoms. By examining 1,000 children, the study aims to identify common skin signs that might speed up detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If skin signs prove useful, this could lead to earlier diagnosis of neurofibromatosis type 2 in children, potentially improving outcomes.

What could go wrong

This is an observational study, not a treatment trial. It may find that skin findings are not reliable enough for early detection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neurofibromatosis 2 NF2-related schwannomatosis skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nice Hospital

    RECRUITING

    Nice, 06000, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••